1Salem AH, Noreddin AM. Moxifloxacin in lower respiratory tract in- fections: in silico simulation of different bacterial resistance and drug exposure scenarios[J]. J Chemother,2014, 26(2) : 80-85.
2Kontou P, Manika K, Chatzika K, et al. Pharmacokinetics of moxi- floxacin and high-dose levofloxacin in severe lower respiratory tract in- fections [ J ]. Int J Antimicrob Agents,2013, 42 ( 3 ) : 262-267.
